جست‌وجوی استاد و پژوهشگر

Edward A. Lemkeمشاهده پروفایل

استاد

• Intrinsically Disordered Proteins
• Neurodegenerative Diseases
• Nucleocytoplasmic Transport
• +۷ مورد دیگر

Edward A. Lemke is a Professor at Johannes Gutenberg University Mainz (JGU), jointly appointed in the Departments of Biology and Chemistry. He serves as Adjunct Director at the Institute of Molecular Biology (IMB) and Visiting Group Leader at EMBL Heidelberg, focusing on intrinsically disordered proteins (IDPs) and their roles in neurodegenerative diseases and essential biological processes like nucleocytoplasmic transport. Education : PhD in Membrane Biophysics (Max Planck Institute/University of Göttingen, 2005), MSc (University of Oklahoma, 2001), Diploma (Technical University of Berlin, 2001) His research pioneers interdisciplinary methods combining synthetic biology, chemical biology, and advanced microscopy to study dynamic protein systems. He has developed novel fluorescence and labeling tools to overcome limitations in analyzing the "dark proteome" of IDPs. Recent work highlights RNA pseudouridylation in designer organelles, SAXS rulers for IDP analysis, and visualizing nuclear transport machinery. His lab's innovations span genetic code expansion, microfluidics, and super-resolution imaging. Scientific Awards : EMBO Member (2022), ERC Advanced Grant (2020), Gutenberg Research Fellow (2018), FEBS Anniversary Award (2017), and multiple competitive grants/awards since 2001 As co-founder of Araxa/Veraxa Biosciences and spokesperson for DFG Priority Program 2191, Lemke bridges academic research and biotechnology commercialization. His lab continues advancing tools for studying complex biological systems.

Andreas Waltherمشاهده پروفایل

استاد

• Polymer Chemistry
• Bioinspired Materials
• DNA Nanotechnology
• +۵ مورد دیگر

Andreas Walther is a full Professor at the Department of Chemistry, Johannes Gutenberg University Mainz, Germany, and a Research Fellow at the Gutenberg Research College and the Max Planck Institute for Polymer Research. With an academic career spanning elite programs like the Bavarian Macromolecular Science Network and a PhD (summa cum laude) from Bayreuth, he leads cutting-edge research in synthetic biology, DNA nanotechnology, and bioinspired materials. Education: PhD (summa cum laude, 2006-2008) in Macromolecular Chemistry, Bayreuth Diploma (2005) in Polymer and Colloid Science, Bayreuth His research focuses on programmable DNA-based materials, chemically fueled reaction networks, and adaptive hydrogels. Recent work explores synthetic cells, transient colloidal assemblies, and non-equilibrium systems. His lab employs deep learning for kinetic modeling, integrates enzymatic networks with soft robotics, and develops pH-responsive materials for biomedical applications. Key article trends include: (1) DNA-driven adaptive systems (2) Enzymatic reaction networks for autonomous behavior (3) Bioinspired metamaterials (4) ATP-powered signaling interfaces (5) Multivalent pattern recognition (6) Sustainable nanocomposites. Scientific Awards: ERC Consolidator Grant (2021) ARCHES Award (2019) ERC Starting Grant (2015/2016) DSM Science Award (2008) Otto Warburg PhD Prize (2009) IUPAC Young Researcher Prize (2018) Walther serves on scientific advisory boards (FRIAS) and leads the DFG Cluster of Excellence livMatS. His lab develops scalable approaches for molecular motor-polymer conjugates, programmable coacervates, and recyclable vitrimers, with applications in tissue engineering and energy-autonomous materials.

• Nuclear envelope biology
• Endoplasmic reticulum biology
• Protein quality control
• +۱۰ مورد دیگر

Christian Schlieker is a Professor of Molecular Biophysics and Biochemistry and Professor of Cell Biology at Yale University School of Medicine. He serves as Director of Undergraduate Studies in the Department of Molecular Biophysics and Biochemistry and is a member of the Advisory Board of the Yale Center for Molecular Discovery. His research spans multiple interdisciplinary programs including the DNA Damage and Genome Integrity Program, Biochemistry, Quantitative Biology, Biophysics and Structural Biology (BQBS), and the Yale Cancer Center. Dr. Schlieker's research focuses on the cellular etiology of movement disorders, with particular emphasis on nuclear compartmentalization and biomolecular condensates. His lab explores how cells build and safeguard the nuclear envelope and endoplasmic reticulum to ensure protein quality control and cellular homeostasis. They investigate how disruptions in membrane organization and phase separation drive the formation of aberrant condensates connected to neurological diseases, particularly movement disorders like dystonia. The lab develops and applies new tools to probe and modulate these processes across scales, integrating cell biology, biochemistry, and computational approaches to uncover fundamental principles of cellular organization. Analysis of Dr. Schlieker's recent publications (2020-2025) reveals a strong focus on nuclear envelope biology, protein quality control mechanisms, and the role of biomolecular condensates in neurological disorders. His work bridges fundamental cell biology with disease mechanisms, particularly in understanding how Torsin ATPases maintain nuclear envelope integrity and how their dysfunction leads to movement disorders. The research spans from molecular mechanisms to potential therapeutic strategies, with several papers identifying small molecule modulators of pathological condensates. Scientific Recognition: NIH Director's New Innovator Award (2011) Service on scientific advisory board of Dystonia Medical Research Foundation Reviewer for NIH, Department of Defense, German Excellence Initiative, and European Research Council As Director of Undergraduate Studies, Dr. Schlieker plays a significant role in academic administration at Yale College. His lab actively recruits graduate students, postdocs, and undergraduates, emphasizing interdisciplinary training that combines biochemical, cellular, and computational approaches. The Schlieker Lab collaborates extensively through the Yale Nucleus Club with the Bahmanyar, King, and Lusk laboratories, creating a rich environment for scientific exchange and skill development. Current research directions include identifying small molecules that modulate aberrant condensates, investigating condensates in neurodevelopmental disorders using patient iPSC lines, establishing FRET-based readouts for protein folding, and elucidating the molecular function of torsin proteins in nuclear pore complex assembly.

• Mechanotransduction
• Integrin signaling
• Vascular biology
• +۶ مورد دیگر

Martin Schwartz is the Robert W. Berliner Professor of Medicine (Cardiology) at Yale School of Medicine, with joint appointments in Biomedical Engineering and Cell Biology. His research program integrates biophysical, cellular, and whole-animal approaches to study fundamental mechanisms of cell adhesion and mechanotransduction with particular relevance to vascular biology and disease. Dr. Schwartz earned his BA in chemistry from New College (1975) and PhD in physical chemistry from Stanford University (1979), followed by postdoctoral training at MIT. He previously held faculty positions at Harvard Medical School, Scripps Research Institute, and the University of Virginia before joining Yale in 2011. His research focuses on four interconnected areas: 1) Mechanotransduction by integrins, 2) Fluid shear stress mechanotransduction in the vascular system, 3) Collateral artery formation, and 4) Aneurysm development. His lab pioneered techniques to measure forces across specific proteins in live cells and has made seminal contributions to understanding how mechanical forces regulate vascular biology and disease. His recent publications (2024-2025) demonstrate continued high-impact research across multiple aspects of vascular mechanobiology, with papers appearing in top journals including Nature Cardiovascular Research, Circulation, and ELife. His work shows consistent focus on the molecular mechanisms by which mechanical forces influence vascular development, physiology, and disease. Notable recognitions include: Fellow of the American Association for Advancement of Science (2016) Fellow of the American Society for Cell Biology (2017) Greenblatt Distinguished Lecture (2021) Bolie Lecture (2019) Joseph Calandra Lecture (2017) As an active mentor, Dr. Schwartz has advised numerous students and postdocs who have become frequent collaborators on his research. His lab participates in Yale's Combined Program in the Biological and Biomedical Sciences (BBS) and maintains strong connections with the Yale Cardiovascular Research Center and Vascular Biology and Therapeutics Program. He serves as Associate Editor for Journal of Cell Biology and on the Editorial Board of Journal of Cell Science, reflecting his commitment to scientific training and scholarly communication. The Schwartz Lab continues to advance our understanding of how cells sense and respond to mechanical forces, with particular emphasis on integrin signaling pathways and their implications for vascular diseases including atherosclerosis and aneurysms. Their multidisciplinary approach bridges basic science discoveries with potential clinical applications in cardiovascular medicine.

Lukas Stelzlمشاهده پروفایل

استادیار

• Computational Biology
• Biophysics
• Liquid-Liquid Phase Separation
• +۵ مورد دیگر

Dr. Lukas Stelzl is a Junior Group Leader at ReALity and IMB Associate Group Leader at the Institute of Molecular Biology (IMB), Johannes Gutenberg University Mainz. He serves as Principal Investigator at the Mainz Institute of Multiscale Modeling (M3ODEL) and Junior Faculty Member at Max Planck Graduate Center. His research employs multi-scale simulations to study biomolecular phase separation mechanisms. Research Focus: The Stelzl Lab investigates how liquid-liquid phase separation regulates cellular processes including: Transcriptional control in health vs. age-related diseases Post-transcriptional regulation during germ cell development Molecular specificity in disordered protein interactions Methodologically, the group develops simulation techniques bridging atomic-scale dynamics and mesoscale condensate formation. Key Collaborations: SFB/TRR 146: Multiscale soft matter simulations ReALity: Resilience and longevity research Max Planck Graduate Center training initiatives Lab website: Stelzl Lab

• cellular metabolism
• supramolecular protein assemblies
• biomolecular condensates
• +۵ مورد دیگر

Dr. Anthony Pedley is an Assistant Professor in the Department of Biochemistry and Molecular Biology at the University of Iowa. He leads the Pedley Research Group, which investigates the organization and regulation of metabolic enzymes in human cells. His work focuses on supramolecular protein assemblies (e.g., purinosomes), biomolecular condensates, and chaperone-mediated processes, with implications for metabolic diseases. Education: BS in Chemistry, Grand Valley State University PhD in Medicinal Chemistry and Molecular Pharmacology, Purdue University Postdoctoral Scholar in Chemistry, The Pennsylvania State University Research Interests: Dr. Pedley's lab explores: (1) Metabolon organization and dynamics using super-resolution microscopy; (2) Chaperone-mediated regulation of enzyme structure/function; and (3) Nutrient-induced degradation of metabolic enzymes. Key areas include cellular metabolism, protein allostery, and therapeutic targeting of condensates. Grants & Collaborations: Actively funded projects include collaborations with Penn State researchers on purinosome stoichiometry. The lab leverages multidisciplinary approaches to decipher metabolic flux regulation. Lab & Resources: The Pedley Research Group utilizes advanced biochemical and imaging facilities to study enzyme assemblies. Current projects emphasize metabolic adaptation in disease contexts.

Wylie Strobergمشاهده پروفایل

استادیار

• Biomechanics
• Biomedical Engineering
• Biomaterials
• +۸ مورد دیگر

Wylie Stroberg is an Assistant Professor in the Department of Mechanical Engineering within the Faculty of Engineering at the University of Alberta. He leads the Computational BioSystems Lab, where he conducts research at the interface between cell biology, physiology and engineering using a range of computational and theoretical techniques. His research interests span multiple areas including: Biomechanics and Biomedical Engineering Biomaterials Mechanics and Materials Composites and Polymers Nano and Micro Materials Computational Mechanics Systems Biology of Proteostasis and the Unfolded Protein Response Reactions in Crowded Cellular Compartments Wetting Phenomena of Nanoscale Structures Dr. Stroberg's research focuses on developing new quantitative techniques for studying complex biological systems across disparate length and time scales. His work has significant implications for understanding cellular physiology, protein homeostasis, and developing new therapeutic approaches for age-associated and protein folding diseases. He employs advanced computational methods including multiscale modeling, machine learning, and theoretical analysis to investigate biological phenomena from the molecular to cellular level. His research group has published extensively in mathematical biology and computational mechanics, with a consistent focus on enzyme kinetics, cellular stress responses, and computational modeling of biological processes. The publications demonstrate a strong interdisciplinary approach combining techniques from mechanical engineering, computational science, and molecular biology. Dr. Stroberg has received recognition for his work in mathematical biology and systems biology, with publications in journals such as the Journal of Theoretical Biology, Biophysical Journal, and Mathematical Biosciences. He currently advises several graduate students working on diverse projects including multiscale modeling of enzymatic nanosensors, protein-based modulation of endoplasmic reticulum shape, development of machine learning-based coarse grained models for high-entropy alloys, and simulation of high-entropy alloys for thermal-spray deposition. His lab has trained undergraduate and master's students who have gone on to further academic pursuits. The Computational BioSystems Lab maintains active collaborations with other researchers at the University of Alberta and beyond, working at the intersection of engineering, biology, and computational science.

Udai B Pandeyمشاهده پروفایل

استاد

• Neurodegenerative Diseases
• ALS Research
• Genetics
• +۴ مورد دیگر

Udai B Pandey serves as a Professor in the Department of Human Genetics at the University of Pittsburgh, where his research centers on molecular mechanisms of neurodegenerative diseases, particularly ALS pathogenesis. His work integrates genetic, cellular, and biochemical approaches to investigate RNA-binding protein dysfunction, nucleocytoplasmic transport defects, and proteostasis collapse in motor neuron degeneration. His educational trajectory includes: PhD in Medical Genetics (1999-2004) from Sanjay Gandhi Postgraduate Institute of Medical Sciences, India Postdoctoral fellowship (2004-2008) in Neurology at the University of Pennsylvania Medical Center under J. Paul Taylor Postdoctoral fellowship (2008-2009) in Developmental Neurobiology at St. Jude Children’s Research Hospital, Memphis TN Dr. Pandey's research program explores how mutations in genes like FUS, TDP-43, and NEK1 drive ALS through disruptions in stress granule dynamics, nuclear import machinery, and microtubule function. His laboratory employs Drosophila models, mammalian cell systems, and patient-derived iPSCs to dissect disease mechanisms, with recent emphasis on phase separation biology and high-throughput drug screening for autophagy modulators. This translational focus bridges fundamental discoveries to therapeutic development for neurodegenerative conditions. Analysis of his 15 most recent publications (2016-2023) reveals consistent investigation into ALS-related proteinopathies, with escalating exploration of phase separation phenomena and genetic modifiers like GEMIN5. His work demonstrates methodological evolution from Drosophila genetics to human iPSC models and structural biology approaches, while maintaining core focus on nucleocytoplasmic transport defects as a unifying ALS mechanism. Scientific recognition includes: Faculty of 1000 Biology 'Must Read Paper' selection (2007) for his Nature publication on HDAC6's role in neuroprotection Dr. Pandey actively mentors graduate students and postdoctoral fellows, as evidenced by trainee-first-author publications spanning molecular genetics and neurobiology. His research program is supported by NIH funding focused on ALS pathogenesis mechanisms, with recent projects examining WNK kinase signaling in cell volume regulation and GEMIN5's role in neurodevelopment. Collaborations span multiple institutions including St. Jude Children's Research Hospital and the University of Pennsylvania. His laboratory operates within the Rangos Research Building at UPMC, utilizing advanced imaging, molecular biology, and high-throughput screening platforms to investigate neurodegenerative disease mechanisms and identify therapeutic targets for ALS and related disorders.